Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Pancreatic Enzymes After Gastrectomy Trial
NCT06058442Phase 3Recruiting
- Sponsor
- Leipzig University
- Start
- Jan 2024
- Primary completion
- Feb 2028
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in gastrectomy comparing NORTASE® with Placebo (2 arms). Primary endpoint: Disease specific quality of life at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
nortase
03
Conditions
gastrectomy
Beyond the preview
Go deeper on NCT06058442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06058442.